Mergers, Acquisitions, and Corporate Restructurings, 6th Edition

Index

Page numbers followed by f and t refer to figures and tables, respectively.

A

AB Acquisitions Ltd, 321t

Abbott Laboratories, 117

AbbVie, 181, 229, 620

Abe, Shinzo, 9

Abenomics, 9

ABL, see Asset-based lending

ABN-AMRO Holding NV, 5t, 6t

Abnormal returns, 268, 269f

Absolute priority rule, 452, 470

Acceptance, pro rata, 83

Acclarent, 126t

Accounting:

for M&As, 608

for share repurchases, 218–219

Accounting rules, 54, 55

Ackman, William, 296f, 301, 400, 410, 411

Acquiring companies (acquirers):

in emerging markets, 72–73, 73t

fifth merger wave, 70–71, 70f, 71f

hedge funds as, 301–308

hurdle rates for, 561–562

serial, 164–165

valuation effects of payment method for, 584–587

Acquisitions, prior, 398–400

Acquisition multiples, 602

Acquisition premiums:

and operating synergy, 144–145

and organizational form, 616–617

Acquisition prices, interest rates and, 563–564, 564f

Actavis, 301

Active antitakeover defenses, 214–247

Activism:

corporate governance, 479–480

effectiveness of, 283–284

and greenmail, 220

by limited partners, 357–359

trends in, 206–207

Activism Blizzard, 175

Activist hedge funds, 291–308

communication between shareholders in, 306–308, 307f

and corporate restructuring, 410–416

functions of, 301–302

and growth of hedge funds, 291, 292f–293f, 293

impact of, 302–306

macroeconomic factors in growth of, 294–300

and proxy fights, 288, 288f

Acxiom Corp., 484

Advantage Companies, 521

Advisory firms, proxy, 284–286

Agee, William, 248

Agency costs, 480–484, 496, 513–514

Agilent ...